Advertisement

Von der Langzeitbehandlung im psychiatrischen Krankenhaus zur Integration in die Gesellschaft: Historischer Hintergrund und Problemstellung

  • S. J. Dencker
  • P. R. A. May
Chapter

Zusammenfassung

Der Verlauf der Schizophrenie ist unterschiedlich. Eine besondere Gruppe chronischer Fälle — die derzeitige Population entspricht in etwa der Gruppe, die vor Einführung der Neuroleptika Anfang der fünfziger Jahre in den psychiatrischen Krankenhäusern war — zeigt verschiedene Formen einer mehr oder weniger schweren Behinderung in medizinischer wie sozialer Hinsicht. Ziel dieses Symposiums über eine Standortbestimmung (»reconnaissance workshop«) ist es, Behandlungsstrategien für diese Gruppe von schwerkranken Patienten zu diskutieren.

Wir sind davon überzeugt, daß viel mehr für diese chronisch schizophrenen Patienten getan werden könnte, wenn bestimmte therapeutische Prinzipien akzeptiert und in der Praxis angewandt würden. Der folgende Beitrag bringt eine kurze Hintergrundbeschreibung des Problems mit Patientencharakteristika, den verschiedenen Einstellungen zu diesem Problem, den wichtigsten Gesichtspunkten der Weiterbehandlung und den zu verwendenden Beziehungsgrößen, um Wirksamkeit und Qualität der Behandlung beurteilen zu können.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literaturverzeichnis

  1. Alanen YO, Rakkolainen V, Rasimus R., Developing the treatment of schizophrenia in a community-psychiatric setting: A psychotherapeutic and family-centered approach. Psychiatr Fenn 1982; 101–120.Google Scholar
  2. Asberg M, Perris C, Schalling D, Sedvall G., The Cprs — Developments and applications of a psychiatric rating scale. Acta Psychiatr Scand 1978; Suppl 271.Google Scholar
  3. Beard JH, Malamud TJ, Rossman E., Psychiatric rehabilitation and long-term rehospi- talization rates: the findings of two research studies. Schizophr Bull 1978; 4: 622–635.PubMedCrossRefGoogle Scholar
  4. Cowden RC, Zax M, Sproles JA., Reserpine: alone and as an adjunct to psychotherapy in the treatment of schizophrenia. Am Med Ass Arch Neurol Psychiatry 1955; 74: 518–522.CrossRefGoogle Scholar
  5. Cowden RC, Zax M, Hague JR., Chlorpromazine. Alone and as an adjunct to group psycho-therapy in the treatment of psychiatric patients. Am J Psychiatry 1956; 113: 898–902.Google Scholar
  6. Dencker SJ., Hospital-based community support services for recovering chronic schizophrenics. New York: World Rehabilitation Fund, 1980.Google Scholar
  7. Dencker SJ, Frankenberg K, Hansen V., Clopenthixol and flupenthixol depot preparations in outpatient schizophrenics. II. Factor analysis of the Cprs subscale for schizophrenia. Acta Psychiatr Scand 1980; Suppl 279: 29–41.Google Scholar
  8. Dencker SJ, Malm U., Combination of neuroleptics and psychosocial therapies in schizophrenia. Nord Psychiatr Tidsskr 1984; 38: 27–30.CrossRefGoogle Scholar
  9. Dencker SJ, Malm U, Lepp M., Schizophrenic relapse after drug withdrawal is predictable. Acta Psychiatr Scand 1986 (im Druck).Google Scholar
  10. Freeman H., Organization of continuous care in schizophrenia. In: What does the schizophrenic outpatient need? Proceedings from a workshop in Copenhagen, February 8–9, 1979: 25–29.Google Scholar
  11. Grinspoon L, EwAlt JR, Shader RI., Schizophrenia, pharmacotherapy and psychotherapy. Baltimore: Williams and Wilkins, 1972.Google Scholar
  12. Hirsch SR, Gaind R, Rohde PD, Stevens BC, Wing JK., Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine, A double-blind placebo trial. Br Med J 1973; 1: 633–637.PubMedCrossRefGoogle Scholar
  13. Hogarty GE, Ulrich RF, Mussare F., Drug discontinuation among long term successfully maintained schizophrenic outpatients. Dis Nerv Syst 1976; 37: 494–500.PubMedGoogle Scholar
  14. Hogarty GE, Schooler NR, Ulrich R., Fluphenazine and social therapy in the aftercare of schizophrenic patients. Arch Gen Psychiatry 1979; 36: 1283–1294.PubMedCrossRefGoogle Scholar
  15. Honigfeld G, Rosenblum MP, Blumenthal IJ., Behavioral improvement in the older schizophrenic patient: drug and social therapies. J Am Geriatr Soc 1964; 13: 57–72.Google Scholar
  16. Johnson Daw., The expectation of outcome from maintenance therapy in chronic schizophrenic patients. Br J Psychiatry 1976; 128: 246–250.PubMedCrossRefGoogle Scholar
  17. Lindberg D., Management of schizophrenia. Long-term clinical studies with special reference to the combination of psychotherapy with depot neuroleptics. Acta Psychiatr Scand 1981; 63 (Suppl 289).Google Scholar
  18. Malm U, May Pra, Dencker SJ., Evaluation of the quality of life of the schizophrenic outpatient: A checklist. Schizophr Bull 1981; 7: 477–487.PubMedCrossRefGoogle Scholar
  19. Malm U., The influence of group therapy on schizophrenia. Acta Psychiatr Scand 1982; 65 (Suppl 297).Google Scholar
  20. May Pra., Treatment of schizophrenia: A comparative study of five treatment methods. New York: Science House, 1968.Google Scholar
  21. May Pra., Rational treatment for an irrational disorder: What does the schizophrenic patient need? Am J Psychiatry 1976; 133: 1008–1012.PubMedGoogle Scholar
  22. Miles CP., Conditions predisposing to suicide: A review. J Nerv Ment Dis 1977; 164: 23 1246.Google Scholar
  23. Roy A, Mazonson A, Pickar D., Attempted suicide in chronic schizophrenia. Br J Psychiatry 1984; 144: 303–306.PubMedCrossRefGoogle Scholar
  24. SJösTRÖM R., Effects of psychotherapy in schizophrenia. A retrospective study. Acta Psychiatr Scand 1985; 71: 513–522.CrossRefGoogle Scholar
  25. Ugelstad E., Psychosocial treatment alternatives for long-stay schizophrenic patients. In: Jorstad J, Ugelstad E, eds. Schizophrenia 75. Oslo: Universitetsforlaget, 1976: 397–412.Google Scholar
  26. Weisbrod BA, Test MA, Stein LI., An alternative to mental hospital treatment: Iii. Economic benefit cost analysis. University of Wisconsin, 1978.Google Scholar
  27. Wing JK, Brown GW., Institutionalism and schizophrenia. A comparative study of three mental hospitals 1960–68. Cambridge: Cambridge University Press, 1979.Google Scholar
  28. Wistedt B., A depot neuroleptic withdrawal study. Acta Psychiatr Scand 1981; 64: 65–84.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Fachmedien Wiesbaden 1988

Authors and Affiliations

  • S. J. Dencker
    • 1
    • 2
  • P. R. A. May
    • 1
    • 2
  1. 1.Lillhagen HospitalGöteborgSchweden
  2. 2.Neuropsychiatric InstituteUniversity of CaliforniaLos AngelesUSA

Personalised recommendations